Medical News

Predictors of Longitudinal Outcomes for Children Using Long‐...
Pediatr Pulmonol.

Demographic, clinical data, and NIV type impact long‐term NIV outcomes and need to be considered during initial...

02 Dec 2020

Pediatrics Predicting Factors for Complications in Periphera...
Acta Pediatr.

Risk factors for complications are comorbidities and sites of insertion other than the upper limbs. In infants, 24G...

25 Nov 2020

Saturation Oxygenation Pressure Index: A Non-invasive Bedsid...
Eur J Pediatr.

SOPI has a significant positive correlation of 82.7% against A-aDO2 and can be a valuable tool to assess...

24 Nov 2020

Impact of Therapeutic Hypothermia on Bleeding Events in Adul...
J Crit Care.

Bleeding complications were common in our study. However, TH (32–34 °C) was not associated with an increased risk...

23 Nov 2020

eCMEs

Date: 4th December 2020
Time: 7:00 pm to 9:00 pm
Date: 4th December 2020
Time: 7:00 pm to 9:00 pm
Date: 4th December 2020
Time: 7:00 pm to 9:00 pm

Key Trials

Colistin & β-lactams – No Significant Difference in Nephrotoxicity Study

This study highlights that colistin is erroneously blamed for nephrotoxicity and nephrotoxicity rates may be over-estimated as AKI is common in...

Simple Intervention Bundle Improves Antimicrobial Stewardship Practices

A simple, low-cost quality intervention bundle can significantly increase appropriate antimicrobial prescribing and appropriate investigations and...

High Rates of Clinical Recovery with Remdesivir in Pregnant Women Hospitalized with Severe COVID-19

Compassionate use of remdesivir in pregnant and postpartum women hospitalized with severe Covid-19 was associated with high clinical recovery rates...

Remdesivir Shortens Time to Recovery in Hospitalized Patients with COVID-19

Treatment with remdesivir shortened the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract...

Slide Library

Cefuroxime (Novacef)

Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....

 
Email this page
Management of Mucormycosis in ENT Practice

Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...

 
Email this page
Antifungal Therapy in Immunocompromised Patients

Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...

 
Email this page
Disseminated Tuberculosis with ARDS

Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...

 
Email this page

Our Publications

Cytorx (Flucytosine) Monograph

This monograph describes the role of Flucytosine tablets in the management of invasive cryptococcal infections and some Candida spp. infections.  

Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections

Parenteral macrolide therapy is needed for patients with moderate to severe CAP/AECB. This booklet gives an overview of the efficacy and safety of...

MRSA: The Clinician’s Challenge

The article summarizes the Indian epidemiological data for MRSA infections, along with treatment of MRSA infections and infection control measures.

Phosome IV (Liposomal Amphotericin B) Monograph

Amphotericin B deoxycholate has a broad antifungal activity, and today it is the best antifungal available against most systemic fungal infections,...

Poll

Do you perceive any clinical benefits of neurotrophic agent in the management of acute brain injury?
Yes
25% (2 votes)
Sometimes
25% (2 votes)
No
50% (4 votes)
Total votes: 8